Gastric cancer, version 2.2013 Journal Article
| Authors: | Ajani, J. A.; Bentrem, D. J.; Besh, S.; D'Amico, T. A.; Das, P.; Denlinger, C.; Fakih, M. G.; Fuchs, C. S.; Gerdes, H.; Glasgow, R. E.; Hayman, J. A.; Hofstetter, W. L.; Ilson, D. H.; Keswani, R. N.; Kleinberg, L. R.; Korn, W. M.; Lockhart, A. C.; Meredith, K.; Mulcahy, M. F.; Orringer, M. B.; Posey, J. A.; Sasson, A. R.; Scott, W. J.; Strong, V. E.; Varghese, T. K. Jr; Warren, G.; Washington, M. K.; Willett, C.; Wright, C. D.; McMillian, N. R.; Sundar, H. |
| Article Title: | Gastric cancer, version 2.2013 |
| Abstract: | The NCCN Clinical Practice Guidelines in Oncology for Gastric Cancer provide evidence- and consensus-based recommendations for a multidisciplinary approach for the management of patients with gastric cancer. For patients with resectable locoregional cancer, the guidelines recommend gastrectomy with a D1+ or a modified D2 lymph node dissection (performed by experienced surgeons in high-volume centers). Postoperative chemoradiation is the preferred option after complete gastric resection for patients with T3-T4 tumors and node-positive T1-T2 tumors. Postoperative chemotherapy is included as an option after a modified D2 lymph node dissection for this group of patients. Trastuzumab with chemotherapy is recommended as first-line therapy for patients with HER2-positive advanced or metastatic cancer, confirmed by immunohistochemistry and, if needed, by fluorescence in situ hybridization for IHC 2+. Copyright © 2013 by the National Comprehensive Cancer Network. All rights reserved. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 11 |
| Issue: | 5 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2013-05-01 |
| Start Page: | 531 |
| End Page: | 546 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 23667204 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 July 2013" - "Source: Scopus" |
Citation Impact
Related MSK Work